Strata Critical Medical (SRTA) Net Margin (2020 - 2026)

Strata Critical Medical has disclosed Net Margin across 7 years of filings, most recently posting 0.37% for Q1 2026.

• In Q1 2026, Net Margin rose 486.0% year-over-year to 0.37%; the TTM figure through Mar 2026 stood at 23.45% (up 3020.0% YoY), while the FY2025 annual figure was 31.15%, up 3874.0% from the prior year.
• Net Margin climbed to 0.37% in Q1 2026, from 5.16% in the prior quarter.
• Over the last five years, Net Margin for SRTA reached as high as 136.06% in Q3 2025 and fell as low as 71.49% in Q4 2023.
• The 5-year median for Net Margin is 5.29% (2025), against an average of 2.17%.
• Annual changes were most pronounced in 2023 — Net Margin plunged 4366 bps — and 2025, when it soared 12587 bps.
• A 5-year view of Net Margin shows it stood at 23.61% in 2022, then tumbled by 403 bps to 71.49% in 2023, then surged by 91 bps to 6.49% in 2024, then advanced by 21 bps to 5.16% in 2025, then soared by 93 bps to 0.37% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 0.37%, 5.16%, and 136.06% for Q1 2026, Q4 2025, and Q3 2025 respectively.